GEVO
Gevo, Inc.
Nasdaq · CIK 1392380
Last close1.31
Daily change-0.01 (-0.76%)
10 Years gain-99.32%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
GEVO · STANDARD
SIC 2860 · Industrial Organic Chemicals · Fiscal year end 1231
Fundamental
69.1Momentum
100.0Acceleration
60.0Confidence
85.0Annual Revenue17
Quarterly Revenue54
Annual CFO15
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth25.0 / 25
Quality18.2 / 25
Capital Efficiency5.1 / 20
Balance Sheet8.6 / 15
Shareholder Economics8.8 / 10
Forward Indicators0.0 / 5
Signals
Operating leverageOperating margin improved by 109.5426 percentage points.
Warnings
ROIC declining · MEDIUMROIC declined by 13.6764 percentage points.
Key Metrics
Revenue Growth TTM317.69%OK
Revenue CAGR 3Y415.09%OK
Gross Marginn/aMISSING
Operating Margin-99.39%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC-28.91%OK
Incremental Operating Margin 3Y-39.23%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y2.17%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $160.58M | n/a | -$20.21M | -$13.40M | -$43.51M | n/a | -12.59% | -27.1% | -3.48% | 234.01M |
| 2025 FY Dec 31, 2024 | $16.92M | n/a | -$90.82M | -$57.38M | -$108.47M | n/a | -536.94% | -641.25% | -20.67% | 231.67M |
| 2024 FY Dec 31, 2023 | $17.20M | n/a | -$81.84M | -$53.72M | -$108.17M | n/a | -475.78% | -628.92% | -21.71% | 238.69M |
| 2023 FY Dec 31, 2022 | $1.18M | n/a | -$102.69M | -$44.31M | -$128.39M | n/a | -8,739.23% | -10,926.64% | -28.64% | 221.54M |
| 2022 FY Dec 31, 2021 | $533,000.00 | n/a | -$60.27M | -$48.27M | -$105.04M | n/a | -11,307.32% | -19,707.5% | -25.92% | 195.79M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $175.57M | sum latest 4 fiscal quarters Revenue | OK | 0001628280-26-054462, 0001392380-25-000032 |
| Revenue Growth TTM | 317.69% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001628280-26-054462, 0001392380-25-000032 |
| Revenue CAGR 3Y | 415.09% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001392380-26-000006 |
| Revenue CAGR 5Y | 96.11% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001392380-26-000006 |
| Gross Profit CAGR 3Y | n/a | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | INSUFFICIENT_HISTORY | derived |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001628280-26-054462, 0001392380-25-000032 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Margin | -99.39% | Operating Income / Revenue | OK | 0001628280-26-054462, 0001392380-25-000032 |
| ROIC | -28.91% | NOPAT / Average Invested Capital | OK | 0001628280-26-054462, 0001392380-25-000032 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001628280-26-054462 |
| Current Ratio | 2.7x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 0.35x | (Cash + Short-term Investments) / Total Debt | OK | 0001628280-26-054462 |
| Revenue per Diluted Share | $0.74 | Revenue / Diluted Shares | OK | 0001628280-26-054462, 0001392380-25-000032 |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |